Abawi, Dawud
Rinaldi, Tommaso
Faragli, Alessandro
Pieske, Burkert
Morris, Daniel A.
Kelle, Sebastian
Tschöpe, Carsten
Zito, Concetta
Alogna, Alessio
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Accepted: 28 April 2021
First Online: 26 May 2021
Declarations
:
: DA reports no conflict of interest. TR reports no conflict of interest. AF is a shareholder of the Company BOCAhealthcare GmbH. BP reports having received consultancy and lecture honoraria from Bayer, Daiichi Sankyo, MSD, Novartis, Sanofi-Aventis, Stealth Peptides, and Vifor Pharma; and editor honoraria from the Journal of the American College of Cardiology. BP and SK received funding from the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research). Sebastian Kelle received an unrestricted research grant from Philips Healthcare and received lecture honoraria from Medis, NL. DAM reports no conflict of interest. CT has received speaker fees and/or contributions to congresses from Abbott, Abiomed, Astra Zeneca, Bayer, Berlin Chemie, Novartis, Pfizer, and Servier; all outside the submitted work. CZ reports no conflict of interest. AA reports no conflict of interest.